Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Prior

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Heart, Lung & Circulation|May 15, 2024
2024 CSANZ Position Statement on Indications, Assessment and Monitoring of Structural and Valvular Heart Disease With Transthoracic Echocardiography in AdultsAdrian Chong, Tony Stanton, Andrew Taylor, et al.
Pulmonary Circulation|June 10, 2026
A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Oral Anticoagulation in Systemic Sclerosis-Related Pulmonary Arterial Hypertension-Results From the SPHInX StudyMandana Nikpour, Alicia Calderone, Susanna M Proudman, et al.
BMJ Open|December 10, 2016
Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocolAlicia Calderone, Wendy Stevens, David Prior, et al.
Arthritis Research & Therapy|June 14, 2012
N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control studyVivek Thakkar, Wendy M Stevens, David Prior, et al.
European Journal of Preventive Cardiology|March 1, 2019
Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohortHein Heidbuchel, Rik Willems, Luc Jordaens, et al.
Rheumatology (Oxford, England)|February 27, 2026
Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvementLaura Ross, Andrew T Burns, André La Gerche, et al.
Nature|May 18, 2017
Extreme hydrothermal conditions at an active plate-bounding faultRupert Sutherland, John Townend, Virginia Toy, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Heart, Lung & Circulation|May 15, 2024
2024 CSANZ Position Statement on Indications, Assessment and Monitoring of Structural and Valvular Heart Disease With Transthoracic Echocardiography in AdultsAdrian Chong, Tony Stanton, Andrew Taylor, et al.
Pulmonary Circulation|June 10, 2026
A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Oral Anticoagulation in Systemic Sclerosis-Related Pulmonary Arterial Hypertension-Results From the SPHInX StudyMandana Nikpour, Alicia Calderone, Susanna M Proudman, et al.
BMJ Open|December 10, 2016
Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocolAlicia Calderone, Wendy Stevens, David Prior, et al.
Arthritis Research & Therapy|June 14, 2012
N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control studyVivek Thakkar, Wendy M Stevens, David Prior, et al.
European Journal of Preventive Cardiology|March 1, 2019
Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohortHein Heidbuchel, Rik Willems, Luc Jordaens, et al.
Rheumatology (Oxford, England)|February 27, 2026
Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvementLaura Ross, Andrew T Burns, André La Gerche, et al.
Nature|May 18, 2017
Extreme hydrothermal conditions at an active plate-bounding faultRupert Sutherland, John Townend, Virginia Toy, et al.
Pageof 7